Acotiamide Hydrochloride, a Therapeutic Agent for Functional Dyspepsia, Enhances Acetylcholine-induced Contraction via Inhibition of Acetylcholinesterase Activity in Circular Muscle Strips of Guinea Pig Stomach

Abstract

Acotiamide is a first-in-class prokinetic drug approved in Japan for the treatment of functional dyspepsia. Given that acotiamide enhances gastric motility in conscious dogs and rats, we assessed the in vitro effects of this drug on the contraction of guinea pig stomach strips and on acetylcholinesterase (AChE) activity in stomach homogenate following fundus removal. We also investigated the serotonin 5-HT₄ receptor agonist mosapride, dopamine D₂ receptor and AChE inhibitor itopride, and representative AChE inhibitor neostigmine. Acotiamide (0.3 and 1 μM) and itopride (1 and 3 μM) significantly enhanced the contraction of gastric body strips induced by electrical field stimulation (EFS), but mosapride (1 and 10 μM) did not. Acotiamide and itopride significantly enhanced the contraction of gastric body and antrum strips induced by acetylcholine (ACh), but not that induced by carbachol (CCh). Neostigmine also significantly enhanced the contraction of gastric body strips induced by ACh, but not that by CCh. In contrast, mosapride failed to enhance contractions induced by either ACh or CCh in gastric antrum strips. Acotiamide exerted mixed inhibition of AChE, and the percentage inhibition of acotiamide (100 μM) against AChE activity was markedly reduced after the reaction mixture was dialyzed. In contrast, itopride exerted noncompetitive inhibition on AChE activity. These results indicate that acotiamide enhances ACh-dependent contraction in gastric strips of guinea pigs via the inhibition of AChE activity, and that it exerts mixed and reversible inhibition of AChE derived from guinea pig stomach.

Key words

acotiamide hydrochloride - acetylcholinesterase - guinea pig - gastric contraction - electrical field stimulation - acetylcholine

• References

• 1 Miwa H, Kusano M, Arisawa T et al. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol 2015; 50: 125-139
• 2 Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-1479
• 3 Matsueda K, Hongo M, Tack J et al. Clinical trial: dose dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia – 100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil 2010; 22: e618-e173
• 4 Matsueda K, Hongo M, Tack J et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012; 61: 821-828
• 5 Tack J, Masclee A, Heading R et al. A dose-ranging, placebo-controlled, pilot trial of Acotiamide inpatients with functional dyspepsia. Neurogastroenterol Motil 2009; 21: 272-280
• 6 Matsunaga Y, Tanaka T, Yoshinaga K et al. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride and mosapride. J Pharmacol Exp Ther 2011; 336: 791-800
• 7 Nagahama K, Matsunaga Y, Kawachi M et al. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs. Neurogastroenterol Motil 2012; 24: 566-574
• 8 Kawachi M, Matsunaga Y, Tanaka T et al. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats. Eur J Pharmacol 2011; 666: 218-225
• 9 Seto K, Sasaki T, Katsunuma K et al. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. Neurogastroenterol Motil 2008; 20: 1051-1059
• 10 Mine Y, Yoshikawa T, Oku S et al. Comparison of effect of mosapride citrate and existing 5-HT₄ receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther 1997; 283: 1000-1008
• 11 Yoshida N, Ito T, Karasawa T et al. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther 1991; 257: 781-787
• 12 Iwanaga Y, Miyashita N, Saito T et al. Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs. Jpn J Pharmacol 1996; 71: 129-137
• 13 Otaka M, Jin M, Odashima M et al. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther 2005; 21 (Suppl. 2) 42-46
• 14 Kinoshita Y, Hashimoto T, Kawamura A et al. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Aliment Pharmacol Ther 2005; 21 ((Suppl. 2)) 37-41
• 15 Hongo M, Harasawa S, Mine T et al. A large-scale, randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS). J Gastroenterol Hepatol 2012; 27: 62-68
• 16 Holtmann G, Talley NJ, Liebregts T et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006; 354: 832-840
• 17 Hallerback BI, Bommelaer G, Bredberg E et al. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther 2002; 6: 959-967
• 18 Talley NJ, Tack J, Ptak T et al. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 2008; 57: 740-746
• 19 Ormsbee HS, Mir SS. The role of the cholinergic nervous system in the gastrointestinal responses to motilin in vivo. In: Duthie HL. (ed.). Gastrointestinal Motility in Health and Disease. Lancaster, England: MTP Press; 1978: 113-124
• 20 Shiba Y, Mizumoto A, Inatomi N et al. Stimulatory mechanism of EM523-induced contractions in postprandial stomach of conscious dogs. Gastroenterology 1995; 109: 1513-1521
• 21 Furuichi A, Makimoto N, Ogishima M et al. In vivo assessment of the regulatory mechanism of cholinergic neuronal activity associated with motility in dog small intestine. Jpn J Pharmacol 2001; 86: 73-78
• 22 Kilbinger H, Wolf D. Effects of 5-HT₄ receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1992; 345: 270-275
• 23 Leclere PG, Lefebvre RA. Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach. Br J Pharmacol 2002; 135: 135-142
• 24 Takahashi T, Kurosawa S, Wiley JW et al. Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pigs. Gastroenterology 1991; 101: 703-710
• 25 Taniyama K, Makimoto N, Furuichi A et al. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J Gastroenterol 2000; 35: 575-582
• 26 Koseki J, Oshima T, Kondo T et al. Role of transient receptor potential ankyrin 1 in gastric accommodation in conscious guinea pigs. J Pharmacol Exp Ther 2012; 341: 205-212
• 27 Ellman GL, Courtney KD, Andres V et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95
• 28 James AN, Ryan JP, Parkman HP. Effects of clonidine and tricyclic antidepressants on gastric smooth muscle contractility. Neurogastroenterol Motil 2004; 16: 143-53
• 29 Ogishima M, Kaibara M, Ueki S et al. Z-338 facilitates acetylcholine release from enteric neurons due to blockade of muscarinic autoreceptors in guinea pig stomach. J Pharmacol Exp Ther 2000; 294: 33-37
• 30 Miyashita N, Iwanaga Y, Kato K et al. Pharmacological studies of HSR-803, a novel gastrointestinal prokinetic agent. Jpn J Pharmacol 1990; 52 ((Suppl. 1)) 274
• 31 Costall B, Naylor RJ, Tan C. Neuronally mediated contraction responses of guinea-pig stomach smooth muscle preparations: modification by benzamide derivatives does not reflect a dopamine antagonist action. Eur J Pharmacol 1984; 102: 79-89
• 32 Ji SW, Park H, Cho JS et al. Investigation into the effects of mosapride on motility of guinea pig stomach, ileum, and colon. Yonsei Med J 2003; 44: 653-664
• 33 Iwanaga Y, Kimura T, Miyashita N et al. Characterization of Acetylcholinesterase-Inhibition by Itopride. Jpn J Pharmacol 1994; 66: 317-322